Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes

OBJECTIVE: ABCC8 mutations cause neonatal diabetes mellitus that can be transient (TNDM) or, less commonly, permanent (PNDM); ∼90% of individuals can be treated with oral sulfonylureas instead of insulin. Previous studies suggested that people with ABCC8-PNDM require lower sulfonylurea doses and hav...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Main Authors: Bowman, Pamela, Mathews, Frances, Barbetti, Fabrizio, Shepherd, Maggie H., Sanchez, Janine, Piccini, Barbara, Beltrand, Jacques, Letourneau-Freiberg, Lisa R., Polak, Michel, Greeley, Siri Atma W., Rawlins, Eamon, Babiker, Tarig, Thomas, Nicholas J., De Franco, Elisa, Ellard, Sian, Flanagan, Sarah E., Hattersley, Andrew T.
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2021
Assuntos:
Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783935/
https://ncbi.nlm.nih.gov/pubmed/33184150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc20-1520
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares